Using Glp-1 Agonist Medications As Part Of A Pre-Diabetes Diet

Using GLP-1 Agonist Medications as Part of a Pre-Diabetes Diet

Pre-diabetes is a condition where blood sugar levels are higher than normal but not high enough to be classified as diabetes. It's estimated that over 100 million Americans have pre-diabetes, and if left untreated, it can increase the risk of developing type 2 diabetes, heart disease, and stroke.

Lifestyle modifications, such as a healthy diet and regular exercise, are the primary mode of management for pre-diabetes. However, for a large proportion of the world's population, lifestyle interventions alone have not facilitated sufficient weight loss. This is where GLP-1 agonist medications come in – a class of medications that can be used as part of a pre-diabetes diet to help manage blood sugar levels and trigger weight loss.

What are GLP-1 Agonist Medications?

GLP-1 agonist medications are injectable medications that mimic the action of a natural hormone called glucagon-like peptide-1 (GLP-1). GLP-1 is released in response to eating and helps to regulate blood sugar levels by stimulating insulin secretion and suppressing glucagon production. GLP-1 agonist medications, such as semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), and tirzepatide (Mounjaro), have shown effectiveness in lowering blood sugar levels and promoting weight loss in people with type 2 diabetes.